| View |
|
HRP-163-12
|
Paracetamol
|
Analgic
|
125 mg / 5 mL
|
Oral Suspension (Orange Flavor)
|
Analgesic / Antipyretic
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
23 July 2022
|
12 July 2026
|
| View |
|
HRP-185-10
|
Ascorbic Acid (as Sodium Ascorbate)
|
Korzid
|
500 mg Capsule (equivalent to 562.43 mg
|
Sodium Ascorbate)
|
Vitamin
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Renewal
|
26 January 2023
|
28 January 2028
|
| View |
|
DRP-1460-04
|
Aluminum Hydroxide + Magnesium Hydroxide + Simethicone
|
Flushcid
|
225 mg/200 mg/25 mg per 5 mL
|
Suspension
|
Antacid
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
23 July 2022
|
05 March 2026
|
| View |
|
DRP-3368-13
|
Paracetamol
|
Analgic
|
100mg / mL Suspension (Oral Drops)
|
Raspberry and Grape Flavor
|
Analgesic / Antipyretic
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
23 July 2022
|
12 July 2026
|
| View |
|
DRP-3369-13
|
Paracetamol
|
Analgic
|
250 mg / 5 mL
|
Oral Suspension (Orange Flavor)
|
Analgesic / Antipyretic
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
23 July 2022
|
12 July 2026
|
| View |
|
DRP-4184-09
|
Paracetamol
|
Analgic
|
500 mg
|
Tablet
|
Analgesic/Antipyretic
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Renewal
|
01 March 2023
|
08 January 2028
|
| View |
|
DRP-5518-24
|
Cefixime (as trihydrate)
|
Katryx
|
100 mg/5 mL
|
Powder for Oral Suspension
|
Antibacterial
|
Zim Laboratories Limited
|
India
|
Renewal
|
29 March 2024
|
17 September 2029
|
| View |
|
DRP-5732-03
|
Betamethasone (as dipropionate) + Gentamicin (as sulfate) + Clotrimazole
|
Beclo-C
|
640 mcg/1 mg/10 mg
|
Topical Cream
|
Corticosteroid (Glucocorticoid)/ Antibacterial (Aminoglycoside)/ Antifungal (Imidazole derivative)
|
Agio Pharmaceuticals Ltd.
|
India
|
CLIDP Conversion
|
23 July 2022
|
10 January 2028
|
| View |
|
DRP-6772-04
|
Tamoxifen (as citrate)
|
None
|
20 mg
|
Film-Coated Tablet
|
Antineoplastic (Anti-Estrogen)
|
General Pharmaceuticals Ltd. (Unit I)
|
Bangladesh
|
CLIDP Conversion
|
23 July 2022
|
27 July 2026
|
| View |
|
DRP-6942-02
|
Multivitamins + Iron
|
Muravit Fe
|
(see below for formulation)
|
Capsule
|
Vitamins and Mineral
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
23 July 2022
|
13 December 2026
|
| View |
|
DRP-6988-03
|
Multivitamins (see formulation reverse side)
|
Muravit E
|
(see formulation reverse side)
|
Tablet
|
Vitamins
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
23 July 2022
|
02 February 2027
|
| View |
|
DRP-7543-03
|
CEFUROXIME (AS AXETIL)
|
XINATRENE
|
250 mg/5 mL
|
Granules for Oral Suspension
|
ANTIBACTERIAL (CEPHALOSPORIN)
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
Renewal
|
24 June 2024
|
14 October 2029
|
| View |
|
DRP-9122-01
|
Omeprazole (as sodium)
|
Omeden
|
40 mg Lyophilized
|
Powder for Injection (I.V.)
|
Proton Pump Inihibitor
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
23 July 2022
|
04 September 2025
|
| View |
|
DRP-9262-03
|
Citicoline (as sodium)
|
Goculine
|
500mg
|
Film-Coated Tablet
|
Psychostimulant/Nootropic
|
Saga Lifesciences Limited
|
India
|
CLIDP Conversion
|
23 July 2022
|
09 November 2025
|
| View |
|
DRP-9885-10
|
Ascorbic acid + Zinc
|
ImmunoVit
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate) / 10 mg (equivalent to 70 mg Zinc Gluconate)
|
Capsule
|
Vitamin / Mineral
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
22 July 2022
|
25 January 2026
|
| View |
|
DRP-10736-02
|
Olmesartan medoxomil
|
OlmeGet
|
20 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Hetero Labs Limited (Unit V)
|
India
|
CLIDP Conversion
|
22 July 2022
|
15 November 2026
|
| View |
|
DRP-12357
|
Febuxostat
|
Furic
|
80 mg
|
Film-Coated Tablet
|
Antigout (Preparation Inhibiting Uric Acid Production)
|
Lupin Ltd.
|
India
|
Renewal
|
15 July 2023
|
11 October 2028
|
| View |
|
DRP-12354
|
Co-Amoxiclav
|
Xinclav 625
|
625mg
|
Film-Coated Tablet
|
-
|
Aurobindo Pharma Limited (Unit XII)
|
India
|
PCPR Conversion
|
22 July 2022
|
29 December 2026
|
| View |
|
DRP-12355
|
Co-Amoxiclav
|
Xinclav 1000
|
1000mg
|
Film-Coated Tablet
|
-
|
Aurobindo Pharma Limited (Unit XII)
|
India
|
PCPR Conversion
|
22 July 2022
|
29 December 2026
|
| View |
|
DRP-2470-10
|
CLOPIDOGREL
|
CLOPIFIRST
|
75 mg
|
Film-Coated Tablet
|
ANTITHROMBOTIC AGENT (PLATELET AGGREGATION INHIBITOR)
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
Renewal
|
20 October 2024
|
02 February 2030
|